fluoxetine and way 100135

fluoxetine has been researched along with way 100135 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciccocioppo, R; Dourish, CT; Massi, M; Panocka, I; Polidori, C1
Dawson, LA; Nguyen, HQ1
Abe, M; Inden, M; Kitamura, Y; Minamino, H; Takata, K; Tooyama, I; Yoshimoto, K1

Other Studies

3 other study(ies) available for fluoxetine and way 100135

ArticleYear
Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats.
    Psychopharmacology, 1997, Volume: 134, Issue:1

    Topics: 5-Hydroxytryptophan; Alcohol Drinking; Animals; Drinking; Eating; Fluoxetine; Injections; Male; Piperazines; Raphe Nuclei; Rats; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists

1997
Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.
    European journal of pharmacology, 1998, Mar-12, Volume: 345, Issue:1

    Topics: Animals; Buspirone; Cyclohexanes; Extracellular Space; Fluoxetine; Male; Microdialysis; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

1998
Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.
    Journal of pharmacological sciences, 2012, Volume: 119, Issue:1

    Topics: Animals; Behavior, Animal; Corpus Striatum; Dopaminergic Neurons; Fluoxetine; Histones; Levodopa; Male; MAP Kinase Signaling System; Oxidopamine; Parkinson Disease; Phosphorylation; Piperazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonergic Neurons; Serotonin; Serotonin 5-HT1 Receptor Antagonists; Substantia Nigra; Tyrosine 3-Monooxygenase

2012